73 results
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
: macrophage A Received regulatory authorization for Phase I/II trial, knee osteoarthritis.
4 | Nasdaq: ENLV DRIVING INNOVATION WITH BALANCED SCIENTIFIC
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
not been conclusively proven to be feasible and has no alternative future use.
Grants received from Israel Innovation Authority, Ministry of Industry … (represented by the Israeli Innovation Authority, the “IIA”), computed on the basis of proceeds from the sale or license of products for development supported
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
have funded our operations primarily through grants from the Israel Innovation Authority (the “IIA”) and the sale of equity and equity linked
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
LIABILITIES
The Company is required to pay royalties to the State of Israel (represented by the Israeli Innovation Authority (the “IIA”)), computed
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
– COMMITMENTS AND CONTINGENT LIABILITIES
The Company is required to pay royalties to the State of Israel (represented by the Israeli Innovation Authority
6-K
EX-99.2
if3c 6xv0e5q
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
7fh8 n78wpt1vn4
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
nrimf
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
dnxu7ibve16
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
ad0 mzj1jgnssrko
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
emu19091h2 h4q
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
lmlun0u vk8
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
wlzn 5nj83wv1phdtsbe
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
so2rdhaqwbqx 325li
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.2
k8g0b ib77
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.3
ixy2u
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
4bfyg5kmmhn pife
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
cghzk1 zfg
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
ct5xbh
27 May 22
Condensed Consolidated Financial Statements
4:39pm